Estrogenic compounds such as 17β-estradiol typically have trophic effects upon carcinoma cells which contain the estrogen receptor, such as the MCF-7 cell line, yet do not have effects on cells that do not express the estrogen receptor, such as the MDA-MB-231 cells, so this compound was added as a control. The gene discussed is ESR1; the disease is carcinoma.